Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) EPS (Weighted Average and Diluted) (2016 - 2023)

Historic EPS (Weighted Average and Diluted) for Ekso Bionics Holdings (EKSO) over the last 11 years, with Q1 2023 value amounting to -$0.33.

  • Ekso Bionics Holdings' EPS (Weighted Average and Diluted) rose 830.58% to -$0.33 in Q1 2023 from the same period last year, while for Mar 2023 it was -$1.22, marking a year-over-year decrease of 3515.34%. This contributed to the annual value of -$1.21 for FY2022, which is 3774.53% down from last year.
  • Per Ekso Bionics Holdings' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.33 for Q1 2023, which was up 830.58% from -$0.35 recorded in Q4 2022.
  • In the past 5 years, Ekso Bionics Holdings' EPS (Weighted Average and Diluted) registered a high of $0.04 during Q3 2019, and its lowest value of -$1.88 during Q2 2020.
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$0.37, with a median of -$0.33 in 2022.
  • In the last 5 years, Ekso Bionics Holdings' EPS (Weighted Average and Diluted) surged by 13636.36% in 2019 and then plummeted by 160000.0% in 2021.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' EPS (Weighted Average and Diluted) stood at $0.04 in 2019, then crashed by 1154.93% to -$0.42 in 2020, then soared by 38.38% to -$0.26 in 2021, then crashed by 33.59% to -$0.35 in 2022, then increased by 4.96% to -$0.33 in 2023.
  • Its EPS (Weighted Average and Diluted) stands at -$0.33 for Q1 2023, versus -$0.35 for Q4 2022 and -$0.33 for Q3 2022.